Latest Capital Raises News

Antares Metals reported a cash outflow in operating activities for Q2 2025 but bolstered its balance sheet with a $1 million placement, positioning itself for focused exploration in Western Australia.

HeraMED has secured pivotal US commercial agreements and achieved a key Australian regulatory milestone, positioning itself for scalable growth in digital maternity care.

Cauldron Energy Limited has unveiled significant uranium discoveries at its Yanrey Project, bolstering its resource base as uranium prices surge on strong global demand and strategic investments.

PTR Minerals has reported significant expansion of its Rosewood Titanium Project, confirming extensive high-grade mineralisation and securing $12 million to accelerate development.

Latrobe Magnesium has resolved a critical manufacturing defect at its Demonstration Plant, enabling Magnesium Oxide production to resume, while securing key financial support for its commercial expansion plans.

WAM Active Limited has launched a $70.7 million entitlement offer at a 7.8% discount, complemented by a $19.3 million placement, following a stellar 40.6% year-to-date portfolio performance. The capital raise aims to fuel further investment in Australian equities.

Audio Pixels has validated a major technical milestone for its digital MEMS speaker array and raised $1.25 million through convertible notes, while securing a $6 million funding commitment to support ongoing development amid continued ASX trading suspension.

White Energy Company Limited has bolstered its balance sheet with a $3.2 million entitlement offer while progressing multiple Australian mineral exploration projects and expanding commercial trials of its Binderless Coal Briquetting technology in South Africa.

Black Rock Mining has marked a significant milestone at its Mahenge Graphite Project with an official groundbreaking ceremony and robust funding progress, setting the stage for rapid development in Tanzania.

Arcadia Minerals Limited has voluntarily suspended trading of its shares pending a significant announcement about a capital raising and earn-in deal at the Swanson Tantalum mine.

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

CONNEQT Health has reported a remarkable surge in Pulse device sales, exceeding 200% growth quarter-on-quarter, while advancing its transition to a recurring revenue model through enterprise contracts and consumer subscriptions.